文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

较低与较高氧饱和度目标对院外心脏骤停复苏后患者出院生存率的影响:EXACT随机临床试验

Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01
一句话结论院外心脏骤停复苏后至ICU前,目标氧饱和度90%–94%较98%–100%未显著改善出院生存率,且缺氧发作更多,作者认为该目标不支持用于院外复苏后。

EXACT为多中心平行组随机试验,纳入院外心脏骤停恢复自主循环、吸100%氧时SpO2≥95%的昏迷成人,由急救人员随机至目标SpO2 90%–94%(干预组n=216)或98%–100%(标准组n=212),至入ICU。主要终点出院生存率:干预组38.3%(82/214)vs 标准组47.9%(101/211),差值-9.6%(95%CI -18.9%至-0.2%),未校正OR 0.68(95%CI 0.46–1.00),P=.05。入ICU前缺氧发作(SpO2<90%)干预组31.3%(67例)vs 标准组16.1%(34例),差值15.2%(95%CI 7.2%–23.1%),OR 2.37(95%CI 1.49–3.79),P<.001。试验因COVID-19疫情提前终止,最终仅入组428例(计划1416例)。

要点

  • 院外心脏骤停复苏后至入ICU前,目标SpO2 90%–94%较98%–100%未显著改善出院生存率:38.3%(82/214)vs 47.9%(101/211),差值-9.6%(95%CI -18.9%至-0.2%),OR 0.68(95%CI 0.46–1.00),P=.05。
  • 干预组入ICU前缺氧发作(SpO2<90%)更多:31.3%(67例)vs 16.1%(34例),差值15.2%(95%CI 7.2%–23.1%),OR 2.37(95%CI 1.49–3.79),P<.001。
  • 9项预设次要终点中8项无显著差异。
  • 作者认为,尽管试验因COVID-19疫情提前终止,结果不支持在院外心脏骤停复苏后使用90%–94%的氧饱和度目标。
  • 试验仅入组428例(计划1416例),因疫情提前终止。

适用人群与场景

  • 院外心脏骤停恢复自主循环的昏迷成人,且吸100%氧时外周氧饱和度(SpO2)至少95%。
  • 场景为院外急救至入ICU前,由急救人员随机分组。

诊断标准与关键阈值

  • 纳入条件:院外心脏骤停恢复自主循环、昏迷、吸100%氧时SpO2≥95%的成人。
  • 干预目标:氧滴定至SpO2 90%–94%(干预组)或98%–100%(标准组),直至到达ICU。

处置流程与药物剂量

  • 由急救人员随机分组后,按目标SpO2 90%–94%或98%–100%进行氧滴定,持续至入ICU。
  • 干预组目标SpO2 90%–94%(n=216),标准组目标SpO2 98%–100%(n=212)。

红旗征与不能漏的情况

  • 入ICU前缺氧发作(SpO2<90%):干预组31.3%(67例)vs 标准组16.1%(34例),OR 2.37(95%CI 1.49–3.79),P<.001。

研究设计与关键结果

  • 多中心、平行组随机临床试验,在澳大利亚维多利亚州和南澳大利亚州的2个急救医疗服务机构和15家医院开展,2017年12月11日至2020年8月11日入组,最终随访日期2021年8月25日;计划入组1416例,实际入组428例,因COVID-19疫情提前终止。
  • 随机428例,425例纳入主要分析(中位年龄65.5岁;女性100例,23.5%),全部完成试验。
  • 主要终点出院生存率:干预组38.3%(82/214)vs 标准组47.9%(101/211),差值-9.6%(95%CI -18.9%至-0.2%),未校正OR 0.68(95%CI 0.46–1.00),P=.05。
  • 9项预设次要终点中8项无显著差异。
  • 入ICU前缺氧发作(SpO2<90%):干预组31.3%(67例)vs 标准组16.1%(34例),差值15.2%(95%CI 7.2%–23.1%),OR 2.37(95%CI 1.49–3.79),P<.001。

证据类型、等级与局限

  • 证据类型:多中心、平行组随机临床试验(EXACT)。
  • 局限:试验因COVID-19疫情提前终止,仅入组428例(计划1416例)。

对床旁实践的改变

  • 作者认为,尽管试验因COVID-19疫情提前终止,结果不支持在院外心脏骤停复苏后使用90%–94%的氧饱和度目标。

指南或共识出处

  • EXACT随机临床试验,ClinicalTrials.gov注册号NCT03138005。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The administration of a high fraction of oxygen following return of spontaneous circulation in out-of-hospital cardiac arrest may increase reperfusion brain injury.

OBJECTIVE: To determine whether targeting a lower oxygen saturation in the early phase of postresuscitation care for out-of-hospital cardiac arrest improves survival at hospital discharge.

DESIGN, SETTING, AND PARTICIPANTS: This multicenter, parallel-group, randomized clinical trial included unconscious adults with return of spontaneous circulation and a peripheral oxygen saturation (Spo2) of at least 95% while receiving 100% oxygen. The trial was conducted in 2 emergency medical services and 15 hospitals in Victoria and South Australia, Australia, between December 11, 2017, and August 11, 2020, with data collection from ambulance and hospital medical records (final follow-up date, August 25, 2021). The trial enrolled 428 of a planned 1416 patients.

INTERVENTIONS: Patients were randomized by paramedics to receive oxygen titration to achieve an oxygen saturation of either 90% to 94% (intervention; n = 216) or 98% to 100% (standard care; n = 212) until arrival in the intensive care unit.

MAIN OUTCOMES AND MEASURES: The primary outcome was survival to hospital discharge. There were 9 secondary outcomes collected, including hypoxic episodes (Spo2 &lt;90%) and prespecified serious adverse events, which included hypoxia with rearrest.

RESULTS: The trial was stopped early due to the COVID-19 pandemic. Of the 428 patients who were randomized, 425 were included in the primary analysis (median age, 65.5 years; 100 [23.5%] women) and all completed the trial. Overall, 82 of 214 patients (38.3%) in the intervention group survived to hospital discharge compared with 101 of 211 (47.9%) in the standard care group (difference, -9.6% [95% CI, -18.9% to -0.2%]; unadjusted odds ratio, 0.68 [95% CI, 0.46-1.00]; P = .05). Of the 9 prespecified secondary outcomes collected during hospital stay, 8 showed no significant difference. A hypoxic episode prior to intensive care was observed in 31.3% (n = 67) of participants in the intervention group and 16.1% (n = 34) in the standard care group (difference, 15.2% [95% CI, 7.2%-23.1%]; OR, 2.37 [95% CI, 1.49-3.79]; P &lt; .001).

CONCLUSIONS AND RELEVANCE: Among patients achieving return of spontaneous circulation after out-of-hospital cardiac arrest, targeting an oxygen saturation of 90% to 94%, compared with 98% to 100%, until admission to the intensive care unit did not significantly improve survival to hospital discharge. Although the trial is limited by early termination due to the COVID-19 pandemic, the findings do not support use of an oxygen saturation target of 90% to 94% in the out-of-hospital setting after resuscitation from cardiac arrest.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03138005.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Bernard SA, Bray JE, Smith K, et al. Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial. JAMA. 2022. PMID: 36286192. doi:10.1001/jama.2022.17701

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。